BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 21095180)

  • 1. The effect of gastric inhibitory polypeptide on intestinal glucose absorption and intestinal motility in mice.
    Ogawa E; Hosokawa M; Harada N; Yamane S; Hamasaki A; Toyoda K; Fujimoto S; Fujita Y; Fukuda K; Tsukiyama K; Yamada Y; Seino Y; Inagaki N
    Biochem Biophys Res Commun; 2011 Jan; 404(1):115-20. PubMed ID: 21095180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LX4211 increases serum glucagon-like peptide 1 and peptide YY levels by reducing sodium/glucose cotransporter 1 (SGLT1)-mediated absorption of intestinal glucose.
    Powell DR; Smith M; Greer J; Harris A; Zhao S; DaCosta C; Mseeh F; Shadoan MK; Sands A; Zambrowicz B; Ding ZM
    J Pharmacol Exp Ther; 2013 May; 345(2):250-9. PubMed ID: 23487174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The incretin hormones GIP and GLP-1 in diabetic rats: effects on insulin secretion and small bowel motility.
    Edholm T; Cejvan K; Abdel-Halim SM; Efendic S; Schmidt PT; Hellström PM
    Neurogastroenterol Motil; 2009 Mar; 21(3):313-21. PubMed ID: 19126188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucose-dependent insulinotropic polypeptide (GIP) stimulates transepithelial glucose transport.
    Singh SK; Bartoo AC; Krishnan S; Boylan MO; Schwartz JH; Michael Wolfe M
    Obesity (Silver Spring); 2008 Nov; 16(11):2412-6. PubMed ID: 18719661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucagon-like peptide-1 secretion is influenced by perfusate glucose concentration and by a feedback mechanism involving somatostatin in isolated perfused porcine ileum.
    Hansen L; Hartmann B; Mineo H; Holst JJ
    Regul Pept; 2004 Apr; 118(1-2):11-8. PubMed ID: 14759551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dissociated effects of glucose-dependent insulinotropic polypeptide vs glucagon-like peptide-1 on beta-cell secretion and insulin clearance in mice.
    Pacini G; Thomaseth K; Ahrén B
    Metabolism; 2010 Jul; 59(7):988-92. PubMed ID: 20153002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of gastric inhibitory polypeptide on human jejunal water and electrolyte transport.
    Helman CA; Barbezat GO
    Gastroenterology; 1977 Feb; 72(2):376-9. PubMed ID: 830596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucose metabolism is altered after loss of L cells and α-cells but not influenced by loss of K cells.
    Pedersen J; Ugleholdt RK; Jørgensen SM; Windeløv JA; Grunddal KV; Schwartz TW; Füchtbauer EM; Poulsen SS; Holst PJ; Holst JJ
    Am J Physiol Endocrinol Metab; 2013 Jan; 304(1):E60-73. PubMed ID: 23115082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concurrent duodenal manometric and impedance recording to evaluate the effects of hyoscine on motility and flow events, glucose absorption, and incretin release.
    Chaikomin R; Wu KL; Doran S; Jones KL; Smout AJ; Renooij W; Holloway RH; Meyer JH; Horowitz M; Rayner CK
    Am J Physiol Gastrointest Liver Physiol; 2007 Apr; 292(4):G1099-104. PubMed ID: 17204542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of glial cell-line derived neurotropic factor family receptor alpha2 in the actions of the glucagon-like peptides on the murine intestine.
    McDonagh SC; Lee J; Izzo A; Brubaker PL
    Am J Physiol Gastrointest Liver Physiol; 2007 Aug; 293(2):G461-8. PubMed ID: 17585017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective sodium-dependent glucose transporter 1 inhibitors block glucose absorption and impair glucose-dependent insulinotropic peptide release.
    Dobbins RL; Greenway FL; Chen L; Liu Y; Breed SL; Andrews SM; Wald JA; Walker A; Smith CD
    Am J Physiol Gastrointest Liver Physiol; 2015 Jun; 308(11):G946-54. PubMed ID: 25767259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduction of hepatic insulin clearance after oral glucose ingestion is not mediated by glucagon-like peptide 1 or gastric inhibitory polypeptide in humans.
    Meier JJ; Holst JJ; Schmidt WE; Nauck MA
    Am J Physiol Endocrinol Metab; 2007 Sep; 293(3):E849-56. PubMed ID: 17609256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of GLP-1 (7-36amide) and GIP on release of somatostatin-like immunoreactivity and insulin from the isolated rat pancreas.
    Schmid R; Schusdziarra V; Aulehner R; Weigert N; Classen M
    Z Gastroenterol; 1990 Jun; 28(6):280-4. PubMed ID: 2238756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of metoclopramide on duodenal motility and flow events, glucose absorption, and incretin hormone release in response to intraduodenal glucose infusion.
    Kuo P; Bellon M; Wishart J; Smout AJ; Holloway RH; Fraser RJ; Horowitz M; Jones KL; Rayner CK
    Am J Physiol Gastrointest Liver Physiol; 2010 Dec; 299(6):G1326-33. PubMed ID: 20829521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucose-dependent insulinotropic polypeptide regulates dipeptide absorption in mouse jejunum.
    Coon SD; Schwartz JH; Rajendran VM; Jepeal L; Singh SK
    Am J Physiol Gastrointest Liver Physiol; 2013 Nov; 305(10):G678-84. PubMed ID: 24072682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The separate and combined impact of the intestinal hormones, GIP, GLP-1, and GLP-2, on glucagon secretion in type 2 diabetes.
    Lund A; Vilsbøll T; Bagger JI; Holst JJ; Knop FK
    Am J Physiol Endocrinol Metab; 2011 Jun; 300(6):E1038-46. PubMed ID: 21386059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. On the physiology of GIP and GLP-1.
    Holst JJ
    Horm Metab Res; 2004; 36(11-12):747-54. PubMed ID: 15655703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of gastric inhibitory polypeptide (GIP) and related analogues on glucagon release at normo- and hyperglycaemia in Wistar rats and isolated islets.
    Cassidy RS; Irwin N; Flatt PR
    Biol Chem; 2008 Feb; 389(2):189-93. PubMed ID: 18163884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Duodenal-jejunal bypass protects GK rats from {beta}-cell loss and aggravation of hyperglycemia and increases enteroendocrine cells coexpressing GIP and GLP-1.
    Speck M; Cho YM; Asadi A; Rubino F; Kieffer TJ
    Am J Physiol Endocrinol Metab; 2011 May; 300(5):E923-32. PubMed ID: 21304061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dietary 1-monoolein decreases postprandial GIP release by reducing jejunal transport of glucose and fatty acid in rodents.
    Shimotoyodome A; Osaki N; Onizawa K; Mizuno T; Suzukamo C; Okahara F; Fukuoka D; Hase T
    Am J Physiol Gastrointest Liver Physiol; 2012 Aug; 303(3):G298-310. PubMed ID: 22651926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.